Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6391607 | 0.68 | — | — | |
| SCHEMBL7192159 | 0.65 | MAOA (0.34) | MAOAMAOB | |
| SCHEMBL3411761 | 0.65 | — | — | |
| SCHEMBL6496926 | 0.64 | ALDH1A1 (0.46) | — | |
| SCHEMBL1162504 | 0.64 | — | — | |
| SCHEMBL13176945 | 0.64 | AKR1B1 (0.32) | — | |
| SCHEMBL10955588 | 0.63 | — | — | |
| SCHEMBL746704 | 0.62 | MAOA (0.40) | MAOAMAOB | |
| SCHEMBL27999339 | 0.62 | MAOA (0.32) | MAOAMAOB | |
| SCHEMBL3003735 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10888622-B2 | Nanocomplexes of modified peptides or proteins | TRUSTEES OF TUFTS COLLEGE (US) | 2021-01-12 | — | — | US | disclosed |
| US-20160129120-A1 | NANOCOMPLEXES OF MODIFIED PEPTIDES OR PROTEINS | TRUSTEES OF TUFTS COLLEGE | 2016-05-12 | — | — | US | disclosed |
| WO-2014186348-A2 | NANOCOMPLEXES OF MODIFIED PEPTIDES OR PROTEINS | TUFTS UNIVERSITY (US) | 2014-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160129120-A1 | NANOCOMPLEXES OF MODIFIED PEPTIDES OR PROTEINS | LNPEP, ACP1, CRYAA | MAOA 4339/4885MAOB 4585/4885 |
| US-10888622-B2 | Nanocomplexes of modified peptides or proteins | LNPEP, ACP1, CRYAA | MAOA 4339/4885MAOB 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.